The pill does n’t contain the hormones estrogen or progesterone. It thins your uterine lining, eliminating your period. It also has the potential to treat endometriosis and fibroids.

The birth control pill already exists, has been extensively researched for both safety and efficacy. It’s mifepristone, better known as the’abortion pill’, that Republicans are currently trying to ban. A focus on mifepristone’s contraceptive properties will help secure mifepristone access around the globe.

Mifepristone showed great promise as a non-hormonal birth control pill. The same mechanism that stops fetal development can also be used to prevent ovulation and thin the uterine lining, making pregnancy impossible.

Research interest in mifepristone seemed to dry up because of abortion stigma. Another compound, ulipristal acetate, held similar promise as an emergency contraceptive and fibroid treatment.

There have been rare but serious instances of liver damage when taken regularly to treat fibroids. Researchers have also found it’s a safer alternative to current endometriosis medications as well as a safe and effective fibroids treatment.

Gemzell danielsson is working with Dr. Rebecca gomperts on a new study to prove that mifepristone can be used as a primary contraceptive.

Women on web will conduct a year-long clinical trial involving nearly 1,000 women in the Netherlands and Moldova. The study was designed in keeping with FDA and European medical agency protocols. It has already recruited seven hospitals as participants and secured all the necessary clinical and ethical approvals to begin the study in Moldova.

The study could open doors for the FDA to approve a low-dose mifepristone contraceptive pill alongside the 200mg abortion pill and 300mg Cushing’s medication.

The Affordable Care Act currently requires insurance companies to cover contraception, but abortion is not necessarily covered. Providers who wish to distribute the abortion pronunciation of mifepristone are bound by regulations that are n’t applied to the Cushing’s product.

The FDA’s requirements can be incredibly challenging to meet. In the best-case scenario, a contraceptive version of mifepristone would still be years away from market.

The study was conducted by mifepristone and mifepristone. There’s no major profit incentive behind the study.

Women on web applied for funding through zonmw’s goed gebruik geneesmiddelen (good use of medicines) program. The application committee said repeated prescriptions run the risk of saving up and illegal resale to induce an abortion.

There are plenty of easily accessible items – including everything from Tylenol to bleach – that can be harmful if used improperly. The European medicines agency and Dutch pharmaceutical agency expressed no such concern when advising on the study.

A decade ago, the oncologist and cancer researcher Dr. Jim Olson launched project violet, a platform where anyone could kick in cash to support research into projects like tumor paint. There’s little concern about women on web enriching itself through research.